<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To examine the association between type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) and survival among patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and to evaluate whether this association varies by sex, insulin treatment, and durations of T2DM and insulin use </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: This study was conducted among 2,278 men and women diagnosed with nonmetastatic colon or <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> between 1992 and 2007 in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Prevention Study-II Nutrition Cohort, a prospective study of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence </plain></SENT>
<SENT sid="2" pm="."><plain>In 1992 to 1993, participants completed a detailed, self-administrated questionnaire </plain></SENT>
<SENT sid="3" pm="."><plain>Vital status and cause of <z:hpo ids='HP_0011420'>death</z:hpo> were ascertained through the end of 2008 </plain></SENT>
<SENT sid="4" pm="."><plain>Multivariable-adjusted relative risks (RRs) and 95% CIs were estimated using Cox proportional hazards regression </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Among the 2,278 men and women with nonmetastatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, there were 842 <z:hpo ids='HP_0011420'>deaths</z:hpo> by the end of follow-up (including 377 <z:hpo ids='HP_0011420'>deaths</z:hpo> from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and 152 <z:hpo ids='HP_0011420'>deaths</z:hpo> from <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>]) </plain></SENT>
<SENT sid="6" pm="."><plain>Among men and women combined, compared with patients without T2DM, patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and T2DM were at higher risk of <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality (RR, 1.53; 95% CI, 1.28 to 1.83), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-specific mortality (RR, 1.29; 95% CI, 0.98 to 1.70), and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-specific mortality (RR, 2.16; 95% CI, 1.44 to 3.24), with no apparent differences by sex or durations of T2DM or insulin use </plain></SENT>
<SENT sid="7" pm="."><plain>Insulin use, compared with no T2DM, was associated with increased risk of <z:hpo ids='HP_0011420'>death</z:hpo> from <z:hpo ids='HP_0000001'>all</z:hpo> causes (RR, 1.68; 95% CI, 1.22 to 2.31) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> (RR, 3.87; 95% CI, 2.12 to 7.08) but not from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (RR, 0.58; 95% CI, 0.28 to 1.19) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and T2DM have a higher risk of mortality than patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> who do not have T2DM, especially a higher risk of <z:hpo ids='HP_0011420'>death</z:hpo> from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
</text></document>